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Abstract
Background: Historically there has been a wide variation in the proportion of inadequate smears
between general practices. Cervical screening in the UK is undergoing a fundamental change by
moving from conventional to liquid based cytology (LBC). The main driver for this change has been
a predicted reduction in the proportions of inadequate samples. This study investigates the effect
of LBC on the variation in the proportion of inadequate samples between general practices using
Shewhart's theory of variation and control charts.
Methods: Routinely collected cervical cytology data was obtained for all general practices in two
localities in South Staffordshire for periods before and after the introduction of liquid based
cytology. Control charts of the proportion of inadequate smears were plotted for the practices
stratified by laboratory. A standardised measure of variation for all of the practices in each
laboratory and each time period was also calculated.
Results: Following the introduction of liquid based cytology the overall proportion of inadequate
samples in the two localities fell from 11.8 to 1.3% (p < 0.05). This fall was associated with a
reduction in the average variation between the GP practices in the two localities from 1.6 to 1.0
standard deviations. There has also been a reduction in the number of practices showing special
cause variation from eight to one following the introduction of liquid based cytology.
Conclusion: A reduction in the proportion of inadequate samples has been realised in these
localities. The reduction in the overall proportion of inadequate samples has also been
accompanied by a reduction in variation between GP practices.
Background
In 2005/06 3.6 million women were screened for cervical
cancer in England, 3.36 million following a formal invita-
tion from the screening programme, generating just under
4.0 million cervical smears [1]. Women who have a smear
which is identified as inadequate by the reporting cytol-
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ogy laboratory must be retested, in line with national
guidelines, and women who have three successive inade-
quate smears are referred for colposcopy [2]. Inadequate
smears are a source of avoidable distress to women, and a
potential waste of resources in general practices, clinics
and cytology laboratories [2].
A study we undertook in South Staffordshire in 2000–01
identified two sources of variation in the proportion of
inadequate smears; that associated with laboratories and
that associated with GP practices [3]. Our study showed
that there was wide variation in the proportion of inade-
quate smears amongst 100 general practices, with 23%
showing evidence of special cause variation which mer-
ited further investigation to identify possible causes. How-
ever, the vast majority of general practices (77%) were
consistent with common cause variation, which, accord-
ing to Shewhart's theory of variation, is best addressed by
introducing fundamental changes to the underlying proc-
ess.
Since then a fundamental change has been made in the
process of collecting and analysing cervical cytology sam-
ples in two of the four localities in the original study, by
introducing Liquid Based Cytology (LBC), a new method
of cervical cell sample preparation. The main driver for
this change was a reduction in the proportion of inade-
quate samples in pilot studies [4,5].
The current study repeated the analysis carried out previ-
ously on this subset of data. The aim is to assess whether
the move to LBC has affected the variation in the propor-
tion of inadequate samples between practices as well as
the overall proportion.
Methods
Cervical cytology data were obtained for all 45 general
practices in two localities in South Staffordshire for the
calendar years 2000 and 2001. The data included the
number of samples taken and the number identified as
inadequate. The corresponding data for the 45 practices in
the two localities was obtained as six month aggregates for
October 2005 – September 2006 following introduction
of LBC into these areas. Both the laboratories serving the
area used the SurePath® LBC system. A number of practice
changes have occurred over this period resulting in
slightly different numbers using each laboratory in the
two study periods.
We undertook analyses of variation by general practice
using P-charts. P-charts are one member of the family of
control charts and are designed to be used with binomial
data (inadequate smear – yes/no) which is expressed as a
proportion of the sample size. We sorted our data by the
total number of samples (ie sample size) and plotted our
P-charts with respect to this order. This has two advan-
tages. Firstly, the resulting P-charts show the impact of
sample size on the control limits, and secondly, the result-
ing control limits are easy on the eye because they appear
like a funnel. Such plots have been advocated in health
care [6].
A standardised variation in the proportion of inadequate
samples was calculated for each practice using the for-
mula:
Where, for each laboratory in each time period, Pobs is the
proportion of inadequate samples observed for each indi-
vidual practice, Pmean the overall mean proportion of inad-
equate samples for all the practices, and Nobs the number
of samples taken for each individual practice. The mean of
the standardised variation for all of the practices in each
laboratory and each time period was then calculated.
Analyses were performed in Microsoft Excel and Stata.
The study was approved by the Pan South Staffordshire
Research Management and Governance Office. The study
protocol was also submitted to South Staffordshire Local
Research Ethics Committee who ruled that ethics commit-
tee approval was not necessary.
Results
Overall the proportion of inadequate samples
The overall proportion of inadequate samples for conven-
tional cytology in the two localities for 2000–01 was
11.8% (11.5% for Laboratory 1 and 12.7% for Laboratory
2) (Figure 1). Following the introduction of LBC the over-
all proportion of inadequate samples fell to 1.3% (p <
0.05) (1.5% for Laboratory 1 and 0.6% for Laboratory 2).
There was a slight increase in the proportion of inade-
quate samples between the first and the second six month
of the study period; 1.4% to 1.8% for Laboratory 1 (p =
0.06) and 0.5% to 0.8% for Laboratory 2 (p = 0.21). The
ratio in the proportion of inadequate samples after/before
the introduction of LBC is 0.11 (95% CI 0.10–0.12) over-
all and 0.13 (0.12–0.15) for Laboratory 1 and 0.05 (0.03–
0.07) for Laboratory 2.
Variation between GP practices
There has been a reduction in the average variation
between the GP practices in the two localities from 1.6 to
1.0 SD in the study period. This has reduced from 1.49 to
1.10 SD for the practices served by Laboratory 1 and from
2.70 to.0.45 SD for the practices served by Laboratory 2.
There has also been a reduction in the number of practices
showing special cause variation from eight in the period
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when conventional cytology was employed to one follow-
ing the introduction of LBC. None of the practices show-
ing special cause variation in the original study show
special cause variation in the current analysis.
Discussion
The expected reduction in the proportion of inadequate
samples following the introduction of LBC has initially
been realised in these localities. A systematic review com-
missioned before the decision (by the National Screening
Committee) to roll out LBC found an overall proportion
of inadequate samples of 0.8% (95% CI 0.1% to 5.5%),
which is comparable to the 1.3% in this study (95% CI
1.2% to 1.5%) [7].
Our findings are contrary to a recent systematic review of
primary studies comparing conventional and LBC tech-
niques that found a median difference in the percentage
Control charts of the proportion of inadequate samples across GP practices by Laboratory, before (Jan 2000 – December  2001) and after (October 2005 – September 2006) the introduction of LBC Figure 1
Control charts of the proportion of inadequate samples across GP practices by Laboratory, before (Jan 2000 – December 
2001) and after (October 2005 – September 2006) the introduction of LBC. Circles indicate the proportion of inadequate sam-
ples for each practice and the blue lines are the upper and lower control limits. Circles between the control limits indicate 
practices are displaying common cause variation. Those outside either line are displaying special cause variation. Common 
cause variation is expected variation attributable to "chance". It is part of every process and affects everyone in that process. 
To reduce common cause variation we need to fundamentally change the underlying process. In contrast, special cause varia-
tion is exceptional variation not attributable to "chance", but arising from special circumstances and therefore not affecting eve-
ryone in that process.
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of unsatisfactory slides of only 0.17% (IQR 0.98% to -
0.37%) [8]. This difference seems mainly due to a higher
proportion of inadequate samples for conventional cytol-
ogy in practice compared to the primary studies [7]; it
remains to be seen if the low proportion of inadequate
samples for LBC can be maintained over the longer term.
The introduction of LBC in these two localities has also
been associated with a reduction in the variation in the
proportion of inadequate samples between GP practices.
Because of the relatively low number of samples taken
after the introduction of LBC, some practices with zero
inadequate samples can still fall above the lower control
limit. However, this affects only one practice served by
each laboratory so any effect would be minimal. There is
further evidence that the introduction of LBC has resulted
in a reduction in variation with only one practice now dis-
playing special cause variation compared to the eight
practices previously.
It seems therefore that the practices in these two localities
are now displaying a more consistent process. This is per-
haps not surprising as the introduction of the new tech-
nique was accompanied by training for all primary care
staff involved in the process as part of local clinical gov-
ernance arrangements. Training was carried in a central-
ised fashion by the PCT Cervical Screening Co-ordinators
using educational material provided by SurePath®.
Attendance at a training session was mandatory prior to
any primary care practitioner (GP or nurse) undertaking
cervical sample-taking with LBC.
Our original study noted a wide variation in the propor-
tion of inadequate samples between all 156 English labo-
ratories [3]. More recently a study has compared the
variability of inadequacy rates in eleven Welsh laborato-
ries following the introduction of LBC using longitudinal
control charts [9]. They reported a reduction in variability
between the laboratories. The results that we present here
indicate this reduction may be mirrored at a practice level,
suggesting that an improvement has been made in the
overall process.
There are a number of limitations in our study. As it is a
before/after comparison changes in other factors, such as
the demographics of the population screened may have
contributed to the results observed. We have demon-
strated a large absolute and relative drop in the propor-
tion of inadequate samples, both overall and for each
laboratory. However, due to limitations in the data we
were unable to adjust this by practice or by age. Neverthe-
less, the size of the change suggests that confounding fac-
tors are unlikely to explain it entirely. We are also unable
to estimate how much of the reduction in both the pro-
portion of inadequate samples and the variation between
practices is due to LBC as a technique or due to other fac-
tors such as mandatory training.
The proportion of inadequate samples are not the only
factor to consider when measuring quality improvement
in cervical screening. Diagnostic accuracy is also impor-
tant. In our original study we found no relationship
between the proportion of smears reported as inadequate
and the positive predictive value of a smear in data from
English laboratories [3]. We have not had the opportunity
to measure any change in the detection of abnormalities
in the current data, though recent reports from two large
medium quality studies (based on the criteria used by
Davey et al [8]) have indicated that LBC has been associ-
ated with an increase in diagnostic accuracy [10,11].
Conclusion
It is clear that the reduction in the proportion of cervical
screening inadequate samples has been realised, at least
initially, in these localities. The reduction in the overall
proportion of inadequate samples has also been accom-
panied by a reduction in variation between GP practices.
The challenge now is to maintain the low proportion of
inadequate samples in the longer term.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
WNH conceived the study, carried out the initial analysis
and drafted the paper. AMJT and SPJ obtained the data
and revised the draft text. MAM carried out further analy-
sis and revised the draft text. All authors contributed to the
final manuscript
Acknowledgements
Thanks to the Cytology Departments at Derby Hospitals NHS Foundation 
Trust and Good Hope Hospital NHS Trust for supplying data, and to the 
Cervical Cytology Steering Group for the former Burntwood, Lichfield and 
Tamworth and East Staffordshire PCTs for their support.
References
1. Cervical Screening Programme England 2005-06 Leeds, The Information
Centre; 2006. 
2. Johnson J, Patnick J: Achievable standards, benchmarks for reporting and
criteria for evaluating cervical cytopathology 2nd edition. Sheffield,
NHSCSP Publications; 2000. 
3. Harrison WN, Mohammed MA, Wall MK, Marshall TP: Analysis of
inadequate cervical smears using Shewhart control charts.
BMC Public Health 2004, 4:25.
4. National Institute for Clinical  Excellence: Technology Appraisal 69.
Guidance on the use of liquid-based cytology for cervical screening London,
National Institute for Clinical Excellence; 2003. 
5. Moss SM, Gray A, Marteau  T, Legood R, Henstock E, Maissi E: Evalu-
ation of HPV/LBC Cervical Screening Pilot Studies. Report to the Depart-
ment of Health London, Department of Health; 2004. 
6. Spiegelhalter D: Funnel plots for institutional comparison.  Qual
Saf Health Care 2002, 11:390-39a.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2007, 7:191 http://www.biomedcentral.com/1471-2458/7/191
Page 5 of 5
(page number not for citation purposes)
7. Karnon J, Peters J, Chilcot J, McGoogan E: Liquid-based cytology in cer-
vical screening: an updated rapid and systematic review Sheffield, The
School of Health and Related Research; 2003. 
8. Davey E, Barratt A, Irwig L, Chan SF, Macaskill P, Mannes P, Saville
AM: Effect of study design and quality on unsatisfactory rates,
cytology classifications, and accuracy in liquid-based versus
conventional cervical cytology: a systematic review.  Lancet
2006, 367:122-132.
9. Fox R, Nix AB, Fielder H: A comparison of variability in Papan-
icolaou and liquid-based cytology inadequacy rates using
Shewhart control charts.  Cytopathology 2006, 17:175-181.
10. Schledermann D, Ejersbo D, Hoelund B: Improvement of diagnos-
tic accuracy and screening conditions with liquid-based
cytology.  Diagnostic Cytopathology 2006, 34:780-785.
11. Kirschner B, Simonsen K, Junge J: Comparison of conventional
Papanicolaou smear and SurePath liquid-based cytology in
the Copenhagen population screening programme for cervi-
cal cancer.  Cytopathology 2006, 17:187-194.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/7/191/pre
pub